ARTICLE | Company News
SkyePharma gets Canadian approval
February 22, 2000 8:00 AM UTC
SkyePharma (LSE:SKP; SKYE) received Canadian marketing approval for DepoCyt, its sustained release formulation of cytarabine to treat meningitis and cancer. SKP also said that in Phase II trials its D...